BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2875649)

  • 1. Healing of chronic Barrett ulcers with omeprazole.
    Hameeteman W; Tytgat GN
    Am J Gastroenterol; 1986 Sep; 81(9):764-6. PubMed ID: 2875649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole.
    Lee FI; Isaacs PE
    Am J Gastroenterol; 1988 Sep; 83(9):914-6. PubMed ID: 3414644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [H2-blocker refractory ulcers: what can be done?].
    Dammann HG
    Z Gastroenterol; 1992 Apr; 30(4):268-71. PubMed ID: 1351328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Barrett's esophagus with H2 blockers.
    Cooper BT; Barbezat GO
    J Clin Gastroenterol; 1987 Apr; 9(2):139-41. PubMed ID: 2883213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
    Mainguet P
    Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
    [No Abstract]   [Full Text] [Related]  

  • 8. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
    Leite LP; Just RJ; Castell DO; Lagerström PO
    Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged cimetidine therapy in ulcerated Barrett's columnar-lined esophagus.
    Delpre G; Kadish U; Glanz I; Avidor I
    Am J Gastroenterol; 1984 Jan; 79(1):8-11. PubMed ID: 6419585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials.
    Classen M; Dammann HG; Domschke W; Hüttemann W; Londong W; Rehner M; Simon B; Witzel L; Berger J
    Hepatogastroenterology; 1985 Oct; 32(5):243-5. PubMed ID: 3908262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding.
    Mohamed SA; al Karawi MA
    Hepatogastroenterology; 1996; 43(10):863-5. PubMed ID: 8884305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. A Scandinavian Multicentre Study.
    Scand J Gastroenterol; 1984 Oct; 19(7):882-4. PubMed ID: 6397846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
    Delchier JC; Soule JC; Mignon M; Goldfain D; Cortot A; Travers B; Isal JP; Bader JP
    Dig Dis Sci; 1986 Jul; 31(7):693-9. PubMed ID: 2873001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antisecretory therapy for prevention of stenoses of bougienage after-burn of esophageal strictures].
    Allakhverdian AS; Mazurin VS; Morozov SV; Isakov VA
    Eksp Klin Gastroenterol; 2003; (4):36-9, 114. PubMed ID: 14653235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB
    Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.